South Africa Accuses Adcock Ingram of Covid-19 Profiteering on Dialysis Machines

1 articles · Updated · Bloomberg · Jun 1

South Africa’s Competition Commission has accused Adcock Ingram of profiteering during the Covid-19 pandemic, exposing the drugmaker to possible antitrust charges.
Baxter International discounts on vital dialysis machines and related drugs sit at the center of the case, with the watchdog alleging Adcock failed to pass those pricing benefits on during the health crisis.
People familiar with the matter said the allegations are not yet public, indicating the case is still at a preliminary stage.
The accusation adds to scrutiny of pandemic-era pricing in South Africa, where competition authorities can pursue excessive-pricing cases tied to essential healthcare products.

A top drug firm allegedly hid life-saving discounts. How deep does profiteering run in South Africa's healthcare industry?

Did Adcock Ingram exploit a crisis, or did it absorb hidden costs to keep vital dialysis services running?

As a pharma giant faces profiteering claims, is the global push for fair pandemic treaties too late for patients?